Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (571-580 of 600) with videos related to

Pageof 60
Sort By:
RMD Open|January 19, 2021
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA studyClementina López-Medina, Anna Molto, Joachim Sieper, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for imaging and soluble biomarkersMaria-Antonietta D'Agostino, Maarten Boers, John Kirwan, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|June 3, 2018
Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritisUta Kiltz, Désirée van der Heijde, Annelies Boonen, et al.
RMD Open|November 9, 2021
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA studyClementina López-Medina, Sylvie Chevret, Anna Molto, et al.
Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2023
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in RemissionJoanna Kedra, Philippe Dieudé, Caroline Giboin, et al.
Pageof 60

Showing results (571-580 of 600) with videos related to

Sort By:
Pageof 60
RMD Open|January 19, 2021
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA studyClementina López-Medina, Anna Molto, Joachim Sieper, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for imaging and soluble biomarkersMaria-Antonietta D'Agostino, Maarten Boers, John Kirwan, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|June 3, 2018
Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritisUta Kiltz, Désirée van der Heijde, Annelies Boonen, et al.
RMD Open|November 9, 2021
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA studyClementina López-Medina, Sylvie Chevret, Anna Molto, et al.
Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2023
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in RemissionJoanna Kedra, Philippe Dieudé, Caroline Giboin, et al.
Pageof 60